Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Monami

Showing results (21-30 of 191) with videos related to

Pageof 20
Sort By:
Diabetes, Obesity & Metabolism|December 7, 2020
Sodium-glucose co-transporter-2 inhibitors and all-cause mortality: A meta-analysis of randomized controlled trialsGiovanni Antonio Silverii, Matteo Monami, Edoardo Mannucci
Diabetes Research and Clinical Practice|October 13, 2007
Comparison of different drugs as add-on treatments to metformin in type 2 diabetes: a meta-analysisMatteo Monami, Caterina Lamanna, Niccolò Marchionni, et al.
International Journal of Cardiology|May 22, 2007
Effect of combined secretagogue/biguanide treatment on mortality in type 2 diabetic patients with and without ischemic heart diseaseMatteo Monami, Niccolò Marchionni, Giulio Masotti, et al.
Diabetes, Obesity & Metabolism|April 12, 2019
Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trialsIlaria Dicembrini, Besmir Nreu, Edoardo Mannucci, et al.
Diabetes, Obesity & Metabolism|October 10, 2019
Glucagon-like peptide-1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta-analysis and subgroup analysis of randomized controlled trialsEdoardo Mannucci, Ilaria Dicembrini, Besmir Nreu, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 24, 2019
Exploring the heterogeneity of the effects of SGLT-2 inhibitors in cardiovascular outcome trialsEdoardo Mannucci, Ilaria Dicembrini, Besmir Nreu, et al.
Diabetes Care|October 26, 2011
Dipeptidyl peptidase-4 inhibitors and bone fractures: a meta-analysis of randomized clinical trialsMatteo Monami, Ilaria Dicembrini, Alessandro Antenore, et al.
Current Medical Research and Opinion|November 24, 2011
Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trialsMatteo Monami, Ilaria Dicembrini, Daniele Martelli, et al.
Acta Diabetologica|June 9, 2009
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysisMatteo Monami, Caterina Lamanna, Niccolò Marchionni, et al.
Diabetes/Metabolism Research and Reviews|January 23, 2004
All-cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanidesEdoardo Mannucci, Matteo Monami, Giulio Masotti, et al.
Pageof 20

Showing results (21-30 of 191) with videos related to

Sort By:
Pageof 20
Diabetes, Obesity & Metabolism|December 7, 2020
Sodium-glucose co-transporter-2 inhibitors and all-cause mortality: A meta-analysis of randomized controlled trialsGiovanni Antonio Silverii, Matteo Monami, Edoardo Mannucci
Diabetes Research and Clinical Practice|October 13, 2007
Comparison of different drugs as add-on treatments to metformin in type 2 diabetes: a meta-analysisMatteo Monami, Caterina Lamanna, Niccolò Marchionni, et al.
International Journal of Cardiology|May 22, 2007
Effect of combined secretagogue/biguanide treatment on mortality in type 2 diabetic patients with and without ischemic heart diseaseMatteo Monami, Niccolò Marchionni, Giulio Masotti, et al.
Diabetes, Obesity & Metabolism|April 12, 2019
Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trialsIlaria Dicembrini, Besmir Nreu, Edoardo Mannucci, et al.
Diabetes, Obesity & Metabolism|October 10, 2019
Glucagon-like peptide-1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta-analysis and subgroup analysis of randomized controlled trialsEdoardo Mannucci, Ilaria Dicembrini, Besmir Nreu, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 24, 2019
Exploring the heterogeneity of the effects of SGLT-2 inhibitors in cardiovascular outcome trialsEdoardo Mannucci, Ilaria Dicembrini, Besmir Nreu, et al.
Diabetes Care|October 26, 2011
Dipeptidyl peptidase-4 inhibitors and bone fractures: a meta-analysis of randomized clinical trialsMatteo Monami, Ilaria Dicembrini, Alessandro Antenore, et al.
Current Medical Research and Opinion|November 24, 2011
Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trialsMatteo Monami, Ilaria Dicembrini, Daniele Martelli, et al.
Acta Diabetologica|June 9, 2009
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysisMatteo Monami, Caterina Lamanna, Niccolò Marchionni, et al.
Diabetes/Metabolism Research and Reviews|January 23, 2004
All-cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanidesEdoardo Mannucci, Matteo Monami, Giulio Masotti, et al.
Pageof 20